← Studies & programmes
Myelin repairPhase 1/2 study in people — safety and possible benefitAccepting participants
ReVIVE: studying clemastine in chronic myelin loss
Published by MyelinWatch:
ReVIVE · Researchers are testing clemastine in people with long-term myelin loss, using MRI measures to look for possible changes.
What is being studied
Researchers are testing clemastine in people with long-term myelin loss, using MRI measures to look for possible changes.
Research stage
Phase 1/2 study in people — safety and possible benefit
The current listing is open to participants.
What we know so far
This Phase 1/2 study is currently open to participants at UCSF. Results are awaited; MRI signals would not by themselves prove better symptoms or function.
What this means for patients today
This is an ongoing study, not an available treatment. The listed centre is in the United States, and eligibility must be checked with the study team.
- Treatment or approach
- Clemastine • long-term loss of myelin
- How it is intended to work
- Uses clemastine to block certain receptors and encourage myelin-making cells to mature
- Where the study is running
- Centre at UCSF, United States • none in Greece
- Published by MyelinWatch
- Last substantive MyelinWatch update